Performs site qualification, site initiation, interim monitoring, site management activities and close-out visits (performed on-site or remotely) ensuring regulatory, ICH-GCP and/or Good Pharmacoepidemiological Practices (GPP) and protocol compliance.
Verifies the process of obtaining informed consent has been adequately performed and documented for each subject/patient. Conducts Source Document Review of appropriate site source documents and medical records; verifies required clinical data entered in the case report form (CRF) is accurate and complete. May perform investigational product (IP) inventory, reconciliation and reviews storage and security. Routinely reviews the Investigator Site File (ISF) for accuracy, timeliness and completeness; reconciles contents of the ISF with the Trial Master File (TMF). Documents activities via confirmation letters, follow-up letters, trip reports, communication logs, and other required project documents. For assigned activities, understands project scope, budgets, and timelines; manages site-level activities / communication to ensure project objectives, deliverables and timelines are met. May act as primary liaison with project site personnel, or in collaboration with another CRA or Central Monitoring Associate (CMA). Prepares for and attends Investigator Meetings and/or sponsor face to face meetings. Provides guidance at the site and project level towards audit readiness standards and supports preparation for audit and required follow-up actions. For Real World Late Phase, the CRA I will use the business card title of Site Management Associate I.